drugset / Trial / NCT02469597

Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis

NCT02469597 ↗

Phase 2 Completed 46 enrolled Northwell Health
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess if administration of an early single dose of a diuretic (furosemide) to children with moderate to severe bronchiolitis can reduce extravascular lung water in an effort to reduce respiratory rate, retractions, intubations, and length of stay.

Timeline

Start
2013-10
Primary completion
2016-04
Completion
2016-04

Outcome

Missed primary endpoint

paper There was no difference in respiratory rates, measured as a decrease of ≥ 25%, at both 2 and 4 h after intervention between furosemide and placebo groups PMID 29174754 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified 1 mg/kg Intravenous

Indications